Impact of Intracoronary Adenosine Administration During Primary PCI | ||||
| Cardiovascular Research Prove Journal | ||||
| Volume 5, Issue 1, June 2021 PDF (51.43 K) | ||||
| Document Type: Abstracts | ||||
| DOI: 10.21608/cvrepj.2021.351598 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Currently myocardial reperfusion with p-PCI is the best treatment strategy for STEMI, However, myocardial perfusion at the cellular level remains impaired despite removal of coronary obstruction in up to 50% of STEMI patients Several methods have been evaluated to improve reperfusion, including heart rate reduction, aspiration thrombectomy and several pharmacological approaches, such as glycoprotein platelet inhibitors, adenosine and drugs able to dilate the microcirculation, seem to be most effective when locally delivered through IC injection, probably because this results in an increased drug bioavailability in the area at risk. | ||||
|
Statistics Article View: 65 PDF Download: 32 |
||||
